Havana, Cuba

Centro De Immunologia Molecular

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 12.5

Forward Citations = 162

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Rolando Perez Rodriguez (3 out of 16 patents)

silverMedal Josefa Lombardero Valladares (2 out of 9 patents)

bronzeMedal Kalet León Monzón (2 out of 7 patents)

4.  Circe Mesa Pardillo (2 out of 8 patents)

5.  Luis Enrique Fernández Molina (2 out of 7 patents)

6.  Belinda Sánchez Ramírez (2 out of 5 patents)

7.  Pradip Nair (1 out of 11 patents)

8.  Sundaraj David Rajkumar (1 out of 6 patents)

9.  Kedarnath Nanjund Sastry (1 out of 19 patents)

10.  Jose Enrique Montero Casimiro (1 out of 12 patents)

11.  Ramakrishnan Melarkode (1 out of 21 patents)

12.  Monalisa Chatterji (1 out of 7 patents)

13.  Laxmi Adhikary (1 out of 12 patents)

14.  Hema Balasubramanian (1 out of 6 patents)

15.  Adys González Palomo (1 out of 1 patent)


8 patents:

Company Overview
Centro de Inmunología Molecular (CIM) is a Cuban biotechnology and pharmaceutical company dedicated to the development of innovative cancer treatments and immunotherapy. With a focus on research and development, CIM strives to provide cutting-edge solutions for patients in need of advanced medical care. Through collaboration with international partners, CIM seeks to improve the lives of individuals affected by cancer worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#4 in Havana

#4 in Cuba

Havana, CU
Havana, Cuba
Forward Citations = 162

47 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Centro De Immunologia Molecular. Retrieved from https://idiyas.com/company/centro-de-immunologia-molecular

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…